602 related articles for article (PubMed ID: 11950779)
1. Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization.
Prueksaritanont T; Subramanian R; Fang X; Ma B; Qiu Y; Lin JH; Pearson PG; Baillie TA
Drug Metab Dispos; 2002 May; 30(5):505-12. PubMed ID: 11950779
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin glucuronidation is minimally and nonselectively inhibited by the fibrates gemfibrozil, fenofibrate, and fenofibric acid.
Goosen TC; Bauman JN; Davis JA; Yu C; Hurst SI; Williams JA; Loi CM
Drug Metab Dispos; 2007 Aug; 35(8):1315-24. PubMed ID: 17470524
[TBL] [Abstract][Full Text] [Related]
3. Effects of fibrates on metabolism of statins in human hepatocytes.
Prueksaritanont T; Tang C; Qiu Y; Mu L; Subramanian R; Lin JH
Drug Metab Dispos; 2002 Nov; 30(11):1280-7. PubMed ID: 12386136
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic studies on metabolic interactions between gemfibrozil and statins.
Prueksaritanont T; Zhao JJ; Ma B; Roadcap BA; Tang C; Qiu Y; Liu L; Lin JH; Pearson PG; Baillie TA
J Pharmacol Exp Ther; 2002 Jun; 301(3):1042-51. PubMed ID: 12023536
[TBL] [Abstract][Full Text] [Related]
5. Acyl-coenzyme a formation of simvastatin in mouse liver preparations.
Li C; Subramanian R; Yu S; Prueksaritanont T
Drug Metab Dispos; 2006 Jan; 34(1):102-10. PubMed ID: 16251252
[TBL] [Abstract][Full Text] [Related]
6. Statin Lactonization by Uridine 5'-Diphospho-glucuronosyltransferases (UGTs).
Schirris TJ; Ritschel T; Bilos A; Smeitink JA; Russel FG
Mol Pharm; 2015 Nov; 12(11):4048-55. PubMed ID: 26412035
[TBL] [Abstract][Full Text] [Related]
7. Lactonization is the critical first step in the disposition of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor atorvastatin.
Jacobsen W; Kuhn B; Soldner A; Kirchner G; Sewing KF; Kollman PA; Benet LZ; Christians U
Drug Metab Dispos; 2000 Nov; 28(11):1369-78. PubMed ID: 11038166
[TBL] [Abstract][Full Text] [Related]
8. UDP-glucuronosyltransferase (UGT) polymorphisms affect atorvastatin lactonization in vitro and in vivo.
Riedmaier S; Klein K; Hofmann U; Keskitalo JE; Neuvonen PJ; Schwab M; Niemi M; Zanger UM
Clin Pharmacol Ther; 2010 Jan; 87(1):65-73. PubMed ID: 19794410
[TBL] [Abstract][Full Text] [Related]
9. In vitro glucuronidation of thyroxine and triiodothyronine by liver microsomes and recombinant human UDP-glucuronosyltransferases.
Tong Z; Li H; Goljer I; McConnell O; Chandrasekaran A
Drug Metab Dispos; 2007 Dec; 35(12):2203-10. PubMed ID: 17875670
[TBL] [Abstract][Full Text] [Related]
10. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
Kaji H; Kume T
Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
[TBL] [Abstract][Full Text] [Related]
11. beta-Oxidation of simvastatin in mouse liver preparations.
Prueksaritanont T; Ma B; Fang X; Subramanian R; Yu J; Lin JH
Drug Metab Dispos; 2001 Oct; 29(10):1251-5. PubMed ID: 11560866
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase.
Vickers S; Duncan CA; Vyas KP; Kari PH; Arison B; Prakash SR; Ramjit HG; Pitzenberger SM; Stokker G; Duggan DE
Drug Metab Dispos; 1990; 18(4):476-83. PubMed ID: 1976071
[TBL] [Abstract][Full Text] [Related]
13. Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization.
Fujino H; Yamada I; Shimada S; Yoneda M; Kojima J
Xenobiotica; 2003 Jan; 33(1):27-41. PubMed ID: 12519692
[TBL] [Abstract][Full Text] [Related]
14. Metabolic interactions between mibefradil and HMG-CoA reductase inhibitors: an in vitro investigation with human liver preparations.
Prueksaritanont T; Ma B; Tang C; Meng Y; Assang C; Lu P; Reider PJ; Lin JH; Baillie TA
Br J Clin Pharmacol; 1999 Mar; 47(3):291-8. PubMed ID: 10215754
[TBL] [Abstract][Full Text] [Related]
15. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
[TBL] [Abstract][Full Text] [Related]
16. Interconversion pharmacokinetics of simvastatin and its hydroxy acid in dogs: effects of gemfibrozil.
Prueksaritanont T; Qiu Y; Mu L; Michel K; Brunner J; Richards KM; Lin JH
Pharm Res; 2005 Jul; 22(7):1101-9. PubMed ID: 16028010
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of oxymetazoline glucuronidation in human liver microsomes: evidence for the involvement of UGT1A9.
Mahajan MK; Uttamsingh V; Gan LS; Leduc B; Williams DA
J Pharm Sci; 2011 Feb; 100(2):784-93. PubMed ID: 20669329
[TBL] [Abstract][Full Text] [Related]
18. Quaternary ammonium-linked glucuronidation of tamoxifen by human liver microsomes and UDP-glucuronosyltransferase 1A4.
Kaku T; Ogura K; Nishiyama T; Ohnuma T; Muro K; Hiratsuka A
Biochem Pharmacol; 2004 Jun; 67(11):2093-102. PubMed ID: 15135306
[TBL] [Abstract][Full Text] [Related]
19. Interactions of human P-glycoprotein with simvastatin, simvastatin acid, and atorvastatin.
Hochman JH; Pudvah N; Qiu J; Yamazaki M; Tang C; Lin JH; Prueksaritanont T
Pharm Res; 2004 Sep; 21(9):1686-91. PubMed ID: 15497697
[TBL] [Abstract][Full Text] [Related]
20. Diabetes mellitus reduces the clearance of atorvastatin lactone: results of a population pharmacokinetic analysis in renal transplant recipients and in vitro studies using human liver microsomes.
Dostalek M; Sam WJ; Paryani KR; Macwan JS; Gohh RY; Akhlaghi F
Clin Pharmacokinet; 2012 Sep; 51(9):591-606. PubMed ID: 22775412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
